This puts Spark in the vanguard of gene and cell therapy, and if approved by the FDA, it will be the first ever gene therapy for a genetic disease to reach the US market.

Global Scientific Director, Flow Cytometry and Targeted Cell Isolation, Labcorp Watch the second of a three-part roundtable series that focus on approaches to accelerating your advanced therapy ...

CAR T-cell therapy for hematologic malignancies requires improved standardization and collaboration between treating teams to optimize patient care. Gene therapy for sickle cell disease shows ...

Branden would be the first person in the world to receive base editing for sickle cell disease, and among the first to receive this method of gene therapy for any condition. Branden agreed to take ...